A clinical prediction rule for pulmonary complications after thoracic surgery for primary lung cancer

Anesthesia and Analgesia

Volumn 110, Issue 5, 2010, Pages 1343-1348

  Amar, David ^a   Munoz, Daisy ^a   Shi, Weiji ^a   Zhang, Hao ^a   Thaler, Howard T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BUPIVACAINE; CARBON MONOXIDE; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FENTANYL; ISOFLURANE; MITOMYCIN; MORPHINE; PACLITAXEL; VECURONIUM; VINBLASTINE;

AGED; ARTICLE; ATELECTASIS; CANCER CHEMOTHERAPY; CANCER SURGERY; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG CANCER; LUNG COMPLICATION; LUNG DIFFUSION; LUNG EMBOLISM; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OXYGEN SUPPLY; PATIENT CONTROLLED ANALGESIA; PNEUMONIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; THORAX SURGERY;

EID: 77951742033     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181bf5c99     Document Type: Article

References (28)

1. Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE II, Landreneau RJ, Inculet RI, Jones DR, Meyers BF, Harpole DH, Putnam JB Jr, Rusch VW. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-9; discussion 1019-1020
2. Jaroszewski DE, Huh J, Chu D, Malaisrie SC, Riffel AD, Gordon HS, Wang XL, Bakaeen F. Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction. J Thorac Cardiovasc Surg 2008;135:648-655
3. Alam N, Park BJ, Wilton A, Seshan VE, Bains MS, Downey RJ, Flores RM, Rizk N, Rusch VW, Amar D. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg 2007;84:1085-91; discussion 1091
4. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest 1994;105:753-759
5. Myrdal G, Gustafsson G, Lambe M, Horte LG, Stahle E. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg 2001;20:694-699
6. Algar FJ, Alvarez A, Salvatierra A, Baamonde C, Aranda JL, Lopez-Pujol FJ. Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg 2003;23:201-208
7. Stephan F, Boucheseiche S, Hollande J, Flahault A, Cheffi A, Bazelly B, Bonnet F. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest 2000;118:1263-1270
8. Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, Heras F. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg 1997;63:944-950
9. Song SW, Lee HS, Kim MS, Lee JM, Kim JH, Nam BH, Zo JI. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection. Ann Thorac Surg 2006;81:1974-1981
10. Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg 1997;11:445-449
11. Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS, White DA. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005;127:1977-1983
12. Brunelli A, Refai MA, Salati M, Sabbatini A, Morgan-Hughes NJ, Rocco G. Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection. Eur J Cardiothorac Surg 2006;29:567-570
13. Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 2008;85:1158-64; discussion 1164-1165
14. Gopal R. Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies. Semin Oncol 2005;32:S55-9
15. Licker MJ, Widikker I, Robert J, Frey JG, Spiliopoulos A, Ellenberger C, Schweizer A, Tschopp JM. Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann Thorac Surg 2006;81:1830-1837
16. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, Weigel TL, Kris MG, Venkatraman ES, Rusch VW. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 2001;72:1149-1154
17. Doddoli C, Barlesi F, Trousse D, Robitail S, Yena S, Astoul P, Giudicelli R, Fuentes P, Thomas P. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005;130:416-425
18. Matsubara Y, Takeda S, Mashimo T. Risk stratification for lung cancer surgery: impact of induction therapy and extended resection. Chest 2005;128:3519-3525
19. Perrot E, Guibert B, Mulsant P, Blandin S, Arnaud I, Roy P, Geriniere L, Souquet PJ. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg 2005;80:423-427
20. Fujita S, Katakami N, Takahashi Y, Hirokawa K, Ikeda A, Tabata C, Mio T, Mishima M. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 2006;29:896-901
21. Licker M, de Perrot M, Spiliopoulos A, Robert J, Diaper J, Chevalley C, Tschopp JM. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg 2003;97:1558-1565
22. Fernandez-Perez ER, Keegan MT, Brown DR, Hubmayr RD, Gajic O. Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy. Anesthesiology 2006;105:14-18
23. Slinger P. Pro: low tidal volume is indicated during one-lung ventilation. Anesth Analg 2006;103:268-270
24. Ferguson MK, Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg 2003;23:35-42
25. Volpino P, Cangemi R, Fiori E, Cangemi B, De Cesare A, Corsi N, Di Cello T, Cangemi V. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer. J Cardiovasc Surg (Torino) 2007;48:375-383
26. Brunelli A, Ferguson MK, Rocco G, Pieretti P, Vigneswaran WT, Morgan-Hughes NJ, Zanello M, Salati M. A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis. Ann Thorac Surg 2008;86:213-218
27. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE Jr, Cross JT Jr, Sherif KD, Weiss KB. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006;144:575-580
28. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007;146:545-555 (Pubitemid 351650535)